Coronavirus Vaccine: Bharat Biotech's Covid-19 shot safe, produced immune response in early human trial | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Monday
June 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
MONDAY, JUNE 05, 2023
Bharat Biotech's Covid-19 shot safe, produced immune response in early human trial

Coronavirus chronicle

Reuters
23 January, 2021, 09:55 am
Last modified: 23 January, 2021, 12:02 pm

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • India launches world’s 1st intranasal Covid vaccine
  • Incepta Pharma abandons Covid vaccine plan
  • ‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Bharat Biotech's Covid-19 shot safe, produced immune response in early human trial

Two formulations of the vaccine, called Covaxin, have been selected for more advanced stages of testing and further efficacy trials are warranted

Reuters
23 January, 2021, 09:55 am
Last modified: 23 January, 2021, 12:02 pm
Representational image. Picture: Collected
Representational image. Picture: Collected

Indian drugmaker Bharat Biotech's coronavirus vaccine, which has been authorized for use in the country, proved safe and produced an immune response in a small group of adults aged 18 to 55, according to a study published in The Lancet medical journal.

The vaccine, developed with the Indian Council of Medical Research (ICMR), is being evaluated in a separate 25,800 person trial, which started in November. Bharat Biotech said on Friday 13,000 people participating in the late-stage trial had been given the second dose.

The interim data published here in the journal included three different vaccine formulations and a placebo group among 375 adults.

Two formulations of the vaccine, called Covaxin, have been selected for more advanced stages of testing and further efficacy trials are warranted, the report said.

Covaxin is an inactivated vaccine that introduces dead virus into the body to trigger an immune response.

This is the first peer reviewed data for the vaccine that has come under scrutiny after widespread criticism over the lack of transparency on the approval process for the shot.

The vaccine was granted emergency approval by the drugs controller general of India this month along with another vaccine, Covishield, developed by AstraZeneca and Oxford University.

India, which has reported the highest number of coronavirus infections after the United States, kicked off its own vaccination drive on Saturday in what the government called the "world's largest vaccination program."

Top News

Bharat Biotech / Bharat Biotech Covid-19 vaccine / Coronavirus Vaccine / covid-19 vaccine / The Lancet / Indian Council of Medical Research (ICMR) / COVAXIN

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • An anatomy of power crisis
    An anatomy of power crisis
  • Photo: PID
    Fuel deals signed with Qatar and Oman, steps taken to buy coal: PM
  • FILE PHOTO: General view of Saudi Aramco's Ras Tanura oil refinery and oil terminal in Saudi Arabia May 21, 2018. REUTERS/Ahmed Jadallah
    Saudi pledges big oil cuts in July as OPEC+ extends deal into 2024

MOST VIEWED

  • Covid is no longer global health emergency: WHO
    Covid is no longer global health emergency: WHO
  • Federal police officers stand guard near the house of former Brazilian President Jair Bolsonaro, during a search operation at his home, in Brasilia, Brazil, 3 May, 2023. REUTERS/Adriano Machado
    Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • World Health Organization logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/Illustration//File Photo
    Covid here to stay but moving out of emergency phase: WHO
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India reports 12,591 new Covid cases today, 20% more than yesterday
  • People queue up outside a quick test centre to take their coronavirus disease (Covid-19) antigen rapid tests, in Singapore September 21, 2021. Photo :Reuters
    Singapore witnesses new Covid wave: ‘Cases are mostly mild’
  • India's active case count now stands at 3.90 per cent. ( HT file Photo)
    India logs 5,676 new Covid cases, active infections cross 37,000-mark

Related News

  • Bolsonaro home raided, phone seized in Brazil vaccine records probe
  • WHO provides 11 lakh bivalent vaccines to Bangladesh: Minister
  • India launches world’s 1st intranasal Covid vaccine
  • Incepta Pharma abandons Covid vaccine plan
  • ‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Features

GarbageMan, launched in 2017, offers a modern, scientific and efficient approach towards waste management. Photo: Courtesy

Beating plastic pollution: Local startups build businesses around waste

1h | Panorama
New battleground of global powers

New battleground of global powers

16h | Panorama
Understanding the Indo-Pacific: A case of two rivalries

Understanding the Indo-Pacific: A case of two rivalries

15h | Panorama
US and its allies in the Ind-Pacific

US and its allies in the Ind-Pacific

16h | Panorama

More Videos from TBS

The fitness industry of Bangladesh tries to reshape from corona effect

The fitness industry of Bangladesh tries to reshape from corona effect

13h | TBS Stories
Ukraine ready to launch counteroffensive

Ukraine ready to launch counteroffensive

17h | TBS World
Mughal Emperor Shah Jahan's food on the streets of Dhaka

Mughal Emperor Shah Jahan's food on the streets of Dhaka

22h | TBS Food
This time Kawali was organized by open library

This time Kawali was organized by open library

1d | TBS Entertainment

Most Read

1
bKash denied permission to pay $4.10 lakh for Argentina football partnership
Banking

bKash denied permission to pay $4.10 lakh for Argentina football partnership

2
Boeing offers Biman its latest 787-10 Dreamliner
Bangladesh

Boeing offers Biman its latest 787-10 Dreamliner

3
Photo: Noor-A-Alam/TBS
Splash

The Night Dhaka did NOT vibe with Anuv Jain

4
Country's first floating solar power plant connected to national grid
Energy

Country's first floating solar power plant connected to national grid

5
File Photo: Mohammad Minhaj Uddin/TBS
Bangladesh

Low-cost housing planned for 4 lakh Bangabandhu Shilpa Nagar workers

6
Photo: TBS
Environment

Green space in Dhaka North declines 66% in 3 decades: Study

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]